| Not Yet Recruiting | Application of Multimodal MRI in Histological Grading and Prognostic Assessment of Rectal Cancer Rectal Neoplasms, Prognosis | — | 2027-11-01 |
| Not Yet Recruiting | Construction and Empirical Research of the Applicable Baduanjin Protocol for Patients With Colorectal Cancer E Colorectal Cancer | N/A | 2025-09-01 |
| Not Yet Recruiting | The Efficacy of Antegrade and Retrograde Enemas Management in Low Anterior Resection Syndrome and Improving th LARS - Low Anterior Resection Syndrome | N/A | 2025-07-20 |
| Not Yet Recruiting | A Real-world Study of the Efficacy and Safety of PD-1 Inhibitors Combined With Chemoradiotherapy in Lung Metas Lung Metastatic Nasopharyngeal Carcinoma | N/A | 2025-07-01 |
| Not Yet Recruiting | Application of the sG8 Scale in Real-World Geriatric Oncology Patients Solid Cancers, Geriatric Assessment | — | 2025-05-16 |
| Not Yet Recruiting | Retrograde and Antegrade Enema for Prevention of LARS After LAR: a Randomized Controlled Trial Low Anterior Resection Syndrome | N/A | 2025-03-25 |
| Not Yet Recruiting | Trial of Gum Chewing to Enhance the Restoration of Intestinal Motility in Colorectal Cancer Surgery Colorectal Cancer (CRC) | Phase 1 / Phase 2 | 2025-03-01 |
| Enrolling By Invitation | Development and Verification of a Screening Tool for Comprehensive Geriatric Assessment of Elderly Tumor Patie Geriatric Assessment, Geriatric Patients, Patients With Cancer | — | 2025-02-05 |
| Not Yet Recruiting | Intravenous Lidocaine Infusion Reduce Postoperative Pulmonary Complications in Patients Undergoing Minimally I Postoperative Pneumonia, Postoperative Pulmonary Atelectasis, Postoperative Pulmonary Edema | N/A | 2025-02-01 |
| Not Yet Recruiting | Reduced Dissemination of Tumor Cells With Primary Ligation of the Inferior Mesenteric Vein in Rectal Cancer Pa Rectal Cancer | N/A | 2025-01-01 |
| Recruiting | Neoadjuvant Chemoradiotherapy Compared to Neoadjuvant Chemotherapy for Luminal-Type Locally Advanced Breast Ca Breast Cancer | N/A | 2024-11-18 |
| Recruiting | Neoadjuvant/Adjuvant Cadonilimab Plus Chemotherapy in Patients With Resectable PD-L1 Negative NSCLC NSCLC | Phase 2 | 2024-08-01 |
| Completed | DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma Intrahepatic Cholangiocarcinoma, Transarterial Chemoembolization, Apatinib | Phase 2 | 2024-07-01 |
| Recruiting | A Cohort Establishment Study of Total Management of Ovarian Cancer Tumor of Female Reproductive System, Ovarian Cancer | — | 2024-06-17 |
| Completed | Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients Gynecological Tumor, Ovarian Cancer, Cervical Cancer | Phase 3 | 2024-05-31 |
| Recruiting | Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients ALK-positive Non-small Cell Lung Cancer, Real World Study | — | 2024-05-01 |
| Unknown | Effect of 3D-printed Reconstruction System in Size of Left DLT Cancer of Lung, Lung Isolation | N/A | 2024-04-01 |
| Recruiting | Study on the Safety and Efficacy of MR-Linac Technique in Patients With Unresectable Locally Advanced Colon Ca Safety and Efficacy | N/A | 2024-04-01 |
| Unknown | Efficacy and Safety of Netupitant and Palonosetron Hydrochloride Capsules in Preventing Nausea and Vomiting In Head and Neck Squamous Cell Carcinoma (HNSCC) | N/A | 2023-11-01 |
| Unknown | 3D-printed Reconstruction Automated Matching System Predicts Size of Double-lumen Tube: a Prospective Double-b Lung Cancer, Lung Diseases, Tracheal Intubation Morbidity | N/A | 2023-11-01 |
| Completed | Association Between Surgical Timing and Route of Total Hysterectomy After LEEP and Perioperative Risk in Patie High-Grade Squamous Intraepithelial Lesions | — | 2023-10-01 |
| Active Not Recruiting | A Retrospective Study of the Efficacy and Safety of Lolatinib in ALK+ NSCLC Patients With Brain or Meningeal M ALK-positive Non-small Cell Lung Cancer, Brain Metastases, Meningeal Metastasis | — | 2023-08-20 |
| Recruiting | Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cervical Cancer | Phase 3 | 2023-07-24 |
| Recruiting | Shared Decision Making in Patients With Lung Cancer Surgery, Lung Adenocarcinoma | — | 2023-02-22 |
| Unknown | The Effect of Nitozumab in the Treatment of Head and Neck Squamous Cell Carcinoma HNSCC | EARLY_Phase 1 | 2023-01-17 |
| Unknown | MRI - Guided Adaptive RadioTHerapy for Dysphagia in Head and Neck Cancer HNSCC | N/A | 2023-01-17 |
| Unknown | A Chinese Patent Medicine Yangzhengxiaoji Capsule to Improve the Nausea of Niraparib in the Maintenance Treatm Ovarian Cancer | Phase 2 | 2022-12-01 |
| Recruiting | A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic N Gynecologic Surgery, High-flow Nasal Cannula, Post-operative Pulmonary Complications | N/A | 2022-11-01 |
| Not Yet Recruiting | Sintilimab Plus NCT or NCRT Versus NCRT for ESCC Esophageal Squamous Cell Carcinoma | Phase 3 | 2022-11-01 |
| Unknown | A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Cervical Cancer | Phase 2 | 2022-10-01 |
| Unknown | Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advance Locally Advanced Nasopharyngeal Carcinoma | N/A | 2022-08-01 |
| Unknown | Tislelizumab +Bevacizumab+pc for Untreated EGFR+ and High PD-L1 Non-squamous NSCLC Non-squamous Non-small Cell Lung Cancer, EGFR Gene Mutation | Phase 2 | 2022-06-01 |
| Unknown | A Phase II Study of Anlotinib Combined With Penpulimab in Subjects With Gynecological Cancer Gynecological Cancer | Phase 2 | 2022-05-10 |
| Recruiting | Nituzumab (Taixinsheng ®） A Prospective, Randomized, Double-blind, Placebo-controlled, Multicenter Phase II Cl Nasopharyngeal Carcinoma | Phase 2 | 2022-04-20 |
| Completed | Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advance Nasopharyngeal Carcinoma | N/A | 2022-03-26 |
| Unknown | Camrelizumab Combination With SBRT and Concurrent Chemotherapy Treated Stage IV Oligometastatic Non-small Cell Non-small Cell Lung Cancer Metastatic | Phase 2 | 2021-12-21 |
| Active Not Recruiting | Selected Chemotherapy Combined Immunotherapy Treated High Risk Patient After NCRT in Resected Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | 2021-07-01 |
| Unknown | Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarco Pulmonary Sarcomatoid Carcinoma, Non-small Cell Lung Cancer, Lung Diseases | Phase 2 | 2021-04-06 |
| Unknown | Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy Non-small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma | Phase 2 | 2021-04-01 |
| Unknown | Dose-painting Radiation for LA-NSCLC Non-small Cell Lung Cancer Stage III, Non-small Cell Lung Cancer Stage II | N/A | 2021-01-01 |
| Unknown | Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma Locally Advanced Esophageal Squamous Cell Carcinoma | Phase 2 | 2020-10-11 |
| Completed | TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC Hepatocellular Carcinoma, Liver Neoplasms, Digestive System Neoplasms | Phase 2 | 2020-09-14 |
| Unknown | Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal Esophageal Squamous Cell Carcinoma, Neoadjuvant Therapy, Surgery | — | 2020-07-01 |
| Unknown | Quantitative Assessment of Blood Supply in the Gastic Conduit With Fluorescence Angiography for Esophageal Rec Esophageal Squamous Cell Carcinoma | N/A | 2020-06-01 |
| Unknown | Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLC Lung Diseases, Neoplasms, Respiratory Tract Diseases | Phase 2 | 2020-05-10 |
| Unknown | Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma | Phase 2 | 2020-03-20 |
| Unknown | Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC Lung Diseases, Neoplasms, Respiratory Tract Diseases | Phase 1 / Phase 2 | 2019-11-01 |
| Unknown | Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC Lung Diseases, Neoplasms, Respiratory Tract Diseases | Phase 2 | 2018-12-30 |
| Unknown | Efficacy and Safety of Anlotinib Plus Platinum Plus Pemetrexed in T790M-negative NSCLC Lung Cancer Metastatic | Phase 1 / Phase 2 | 2018-12-06 |
| Unknown | Anlotinib Versus Docetaxel as the Second-line Treatment in EGFR Wild Type Patients With Advanced NSCLC Lung Cancer, Lung Cancer Metastatic | Phase 2 | 2018-10-16 |
| Unknown | PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phas Nasopharyngeal Carcinoma, PD-1 Inhibitors, Chemoradiotherapy | Phase 2 | 2018-08-01 |
| Unknown | Efficacy and Safety of Apatinib As Third Line Therapy in Patients With Advanced Ovarian Cancer Angiogenesis Inhibitors，Ovarian Neoplasms | Phase 2 | 2017-08-27 |
| Unknown | Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation Lung Cancer Stage IV | Phase 2 | 2017-06-02 |
| Completed | Maintenance Therapy of Apatinib After Chemoradiotherapy in Metastatic Nasopharyngeal Carcinoma Nasopharyngeal Neoplasms | Phase 2 | 2017-04-01 |
| Unknown | Apatinib and Etoposide as the Maintenance Therapy in Extensive-stage Small Cell Lung Cancer After First-line C Extensive-stage Small Cell Lung Cancer, Lung Cancer | Phase 2 | 2017-03-01 |
| Completed | Chemoradiotherapy With or Without Enteral Nutrition for Locally Advanced Thoracic Esophageal Carcinoma Esophageal Squamous Cell Carcinoma, Enteral Nutrition Therapy, Chemoradiotherapy | Phase 3 | 2014-09-01 |
| Unknown | Changes in Tumor Tissue and Serum Biomarkers Before and After Cetuximab Combined With Preoperative Radiotherap Locally Advanced Thoracic Middle-lower Segment Esophageal Squamous Cell Carcinoma | Phase 2 | 2014-04-01 |
| Unknown | The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC） Oligo-metastatic Stage IV Non-small Cell Lung Cancer | Phase 3 | 2014-01-01 |
| Unknown | Cisplatin and Gemcitabine With or Without Bevacizumab in EGFR Wild-type Non-Small Cell Lung Cancer Lung Cancer | Phase 2 | 2013-02-01 |
| Unknown | Outcomes of Smoker and Drinker With Esophageal Squamous Cell Carcinoma After Esophagectomy Outcomes of Smoker and Drinker After Esophagectomy | — | 2010-02-01 |
| Completed | Effect of Cervical Paraesophageal Lymph Node Metastasis Versus Supraclavicular Lymph Node Metastasis on the Ov Esophageal Cancer | — | 2009-01-01 |